ImmunoBiome Inc.

Development of disease-specific microbiome-targeted therapeutics
Development of anti-inflammatory, anti-cancer immune-enhancing pharmabiotics
Development of microbiome-mediated therapies targeting autoimmunity, transplant rejection, and neurological diseases


Vision

To lead the global market of microbiome-mediated therapeutics

To lead the global development of drugs against incurable diseases




Microbiome-targed therapeutics starts here